EMA Withdrawn: Allex (desloratadine) — Schering-Plough Europe

View source ↗

Summary

Desloratadine product Allex (Schering-Plough Europe) has been withdrawn from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis
• Urticaria

Drugs mentioned

• Allex (desloratadine)

Snippet

Status: Withdrawn. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Schering-Plough Europe. Decision date: 31/12/2009